PARP1 interacts with WDR5 to enhance target gene recognition and facilitate tumorigenesis

Yali Qin1, Xiaochuan Dong2, Manman Lu1

  • 1School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.

Cancer Letters
|May 16, 2024
PubMed

Insights

Poly (ADP-ribose) polymerase-1 (PARP1) interacts with WDR5 to regulate gene expression and chromatin. Combined inhibition of WDR5 and PARP1 significantly hinders cancer cell proliferation, revealing new therapeutic targets.

Area of Science:

  • Molecular Biology
  • Epigenetics
  • Cancer Research

Background:

  • Poly (ADP-ribose) polymerase-1 (PARP1) is crucial for DNA damage repair.
  • PARP1's role in chromatin recognition and gene expression regulation requires further elucidation.
  • Understanding PARP1's interaction with chromatin modifiers is key to its non-canonical functions.

Purpose of the Study:

  • To investigate the interaction between PARP1 and SET1/MLL complexes, specifically with WDR5.
  • To determine the impact of PARP1 on WDR5 binding and histone methylation at specific gene loci.
  • To explore the therapeutic potential of targeting the PARP1-WDR5 interaction in cancer.

Main Methods:

  • Co-immunoprecipitation assays to confirm protein interactions.
  • Chromatin immunoprecipitation (ChIP) to assess locus-specific binding and histone modifications.
  • Cell proliferation assays to evaluate the combined effect of WDR5 and PARP1 inhibition.

Main Results:

  • PARP1 directly binds to WDR5, a component of SET1/MLL complexes.
  • PARP1 influences locus-specific WDR5 binding and H3K4 methylation without altering global levels.
  • Inhibition of the WDR5 Win site disrupts PARP1-WDR5 interaction and target gene binding.
  • Combined inhibition of WDR5 and PARP1 demonstrates potent anti-proliferative effects in cancer cells.

Conclusions:

  • PARP1 and WDR5 cooperate in chromatin recognition and target gene expression.
  • The WDR5 Win site is critical for PARP1 recruitment to target genes.
  • Targeting the PARP1-WDR5 axis offers a promising strategy for cancer therapy.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Long-patch Base Excision Repair01:02

Long-patch Base Excision Repair

Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.5K